Loading…
Nuturna International LLC marketed "Diabetic Support Formula" as a dietary supplement while making disease claims that classified it as an unapproved new drug under federal law. The company violated the Federal Food, Drug, and Cosmetic Act by including customer testimonials on its website and Amazon storefront describing the product's use for treating, mitigating, and preventing diabetes and controlling blood sugar levels—claims that establish intended drug use rather than dietary supplement use. The FDA and Federal Trade Commission jointly reviewed the company's online marketing materials in August 2021 and determined the product lacked required FDA approval for the therapeutic claims being made.